zika
fever
mosquitoborn
infecti
diseas
caus
zika
viru
zikv
epidem
diseas
effect
therapi
establish
recent
outbreak
zikv
brazil
french
polynesia
link
consider
increas
incid
fetal
microcephali
diseas
guillainbarr
syndrom
current
specif
therapi
vaccin
earli
exploit
method
prevent
expans
zikv
high
prioriti
valid
commonli
use
antivir
drug
evalu
effect
ribavirin
drug
use
treat
hepat
c
interferonb
ifnb
zikv
replic
mammalian
cell
observ
inhibitori
effect
ribavirin
zikv
replic
zikvinduc
cell
death
without
cytotox
effect
furthermor
found
mice
lack
type
ifn
signal
highli
sensit
zikv
infect
exhibit
lethal
outcom
ribavirin
abrog
viremia
zikvinfect
mice
data
suggest
inhibit
viral
rnadepend
rna
polymeras
may
effect
treatment
zikv
infect
data
provid
new
insight
mechan
inhibit
zikv
replic
prevent
zika
fever
zikv
arthropodborn
viru
arboviru
genu
flaviviru
includ
dengu
viru
denv
west
nile
viru
yellow
fever
viru
japanes
enceph
viru
lanciotti
et
al
solomon
zikv
isol
first
time
rhesu
monkey
zika
forest
uganda
dick
b
zikv
transmit
human
mosquito
especi
aed
aegypti
aed
albopictu
symptom
infect
includ
fever
skin
rash
arthralgia
conjunct
hay
patient
asymptomat
duffi
et
al
petersen
et
al
slavov
et
al
zikv
infect
human
virus
african
asian
lineag
margin
import
end
centuri
howev
first
outbreak
report
yap
island
micronesia
viru
transmit
aed
aegypti
lanciotti
et
al
widespread
epidem
asian
lineag
zikv
report
new
caledonia
french
polynesia
zikv
reach
brazil
shortli
thereaft
viru
spread
among
countri
south
central
america
faria
et
al
number
case
pregnancyassoci
microcephali
suddenli
increas
brazil
close
associ
concurr
outbreak
zikv
grow
bodi
evid
indic
zikv
infect
pregnant
women
caus
congenit
abnorm
fetal
demis
brasil
et
al
li
et
al
miner
et
al
sarno
et
al
ventura
et
al
howev
mechan
underli
phenomena
remain
unknown
therapi
case
establish
type
interferon
receptor
defici
mice
sustain
high
zikv
load
brain
spinal
cord
die
infect
wherea
wildtyp
mice
resist
zikv
furthermor
zikvinfect
pregnant
mice
sjl
strain
yield
pup
congenit
fetal
abnorm
cugola
et
al
sjl
mice
carri
mutat
gene
critic
type
ifn
signal
izumi
et
al
studi
indic
zikv
transmiss
fetu
lead
defect
fetal
develop
suggest
type
ifn
respons
play
import
role
zikv
phylaxi
mice
antivir
drug
ribavirin
use
treatment
hepat
c
viru
hcv
infect
combin
type
ifn
abdelhadi
et
al
bansal
et
al
ribavirin
exert
antivir
effect
inhibit
viral
rnadepend
rna
polymeras
bougi
bisaillon
maag
et
al
toltzi
et
al
inhibit
mrna
cap
format
goswami
et
al
upregul
gene
relat
ifn
signal
feld
et
al
zhang
et
al
well
mechan
like
zikv
denv
hcv
member
famili
flavivirida
recent
work
show
ribavirin
inhibit
denv
replic
vero
cell
rattanabure
et
al
suggest
drug
might
also
effect
inhibitor
zikv
replic
studi
investig
effect
ribavirin
ifnb
zikv
replic
found
combin
ribavirin
ifnb
well
ribavirin
ifnb
alon
inhibit
zikv
replic
vitro
could
inhibit
viral
replic
vero
cell
monkey
cell
line
cell
human
cell
line
cell
mosquito
cell
line
moreov
found
mice
carri
null
mutat
gene
encod
essenti
type
ifn
signal
highli
suscept
lethal
infect
zikv
final
found
administr
ribavirin
inhibit
earli
stage
viremia
zikvinfect
mice
taken
togeth
result
indic
ribavirin
potent
inhibit
zikv
replic
vitro
vivo
administr
rna
polymeras
inhibitor
may
effect
treatment
strategi
prevent
zikv
infect
zika
viru
mr
uganda
kindli
provid
rockefel
univers
new
york
ny
usa
vero
cell
african
green
monkey
kidney
cell
maintain
c
co
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
uml
penicillin
mgml
streptomycin
cell
aed
albopictu
maintain
c
co
complet
mem
consist
eagl
mem
nissui
tokyo
japan
lalanylglutam
acid
gibco
glutamax
thermo
fisher
scientif
waltham
usa
nonessenti
amino
acid
thermo
fisher
scientif
sodium
bicarbon
thermo
fisher
scientif
fb
hyclon
fb
thermo
fisher
scientif
zikv
subsequ
propag
cell
complet
mem
mice
meraz
et
al
kindli
provid
akihiko
yoshimura
keio
univers
tokyo
japan
male
mice
age
week
use
throughout
studi
mice
kept
specif
pathogenefre
facil
divis
laboratori
anim
scienc
oita
univers
oita
japan
experi
use
mice
approv
perform
accord
guidelin
oita
univers
anim
ethic
committe
ribavirin
purchas
nacalai
tesqu
kyoto
japan
ganciclovir
purchas
wako
osaka
japan
recombin
human
ifnb
purchas
peprotech
rocki
hill
nj
usa
confluent
vero
cell
cell
cell
cultur
plate
costar
corn
ny
usa
infect
zikv
dilut
complet
mem
multipl
infect
moi
vero
cell
cell
cell
follow
h
adsorpt
c
complet
mem
contain
ribavirin
mgml
andor
ifnb
uml
ad
cell
subsequ
cell
incub
day
c
co
humidifi
environ
total
rna
isol
vero
cell
cell
cell
use
trizol
reagent
thermo
fisher
scientif
cdna
gener
mg
total
rna
use
verso
cdna
kit
thermo
fisher
scientif
realtim
rtpcr
perform
use
zikv
primer
zikvqpf
zikvqpr
tabl
lanciotti
et
al
amplif
target
fragment
perform
roch
basel
switzerland
use
kapa
sybr
fast
qpcr
kit
kapa
biosystem
wilmington
usa
data
normal
correspond
level
mrna
encod
bactin
ribosom
protein
express
leme
et
al
amplif
condit
follow
cycl
c
c
primer
zikv
bactin
ribosom
protein
purchas
fasmac
kanagawa
japan
sequenc
primer
list
tabl
determin
viral
titer
confluent
vero
cell
cultur
plate
infect
serial
dilut
zikv
complet
mem
follow
h
adsorpt
c
methylcellulos
mp
biomed
aurora
oh
usa
layer
cell
subsequ
cell
incub
day
c
co
humidifi
environ
fix
formalin
wako
stain
methylen
blue
wako
count
plaqu
examin
effect
ribavirin
ifnb
ganciclovir
zikv
replic
vero
cell
infect
zikv
moi
describ
methylcellulos
contain
ribavirin
mgml
ifnb
uml
ganciclovir
mm
mgml
layer
four
day
plate
photograph
confluent
vero
cell
cultur
plate
infect
zikv
dilut
complet
mem
moi
follow
h
adsorpt
c
complet
mem
contain
ribavirin
mgml
ad
four
day
treatment
cell
observ
microscop
biorevo
keyenc
osaka
japan
photograph
cell
trypsin
collect
along
supernat
cell
viabil
determin
stain
fitceannexin
v
biolegend
san
diego
ca
usa
zombi
red
fixabl
viabil
kit
biolegend
stain
data
acquir
use
fac
bd
lsrfortessa
bd
bioscienc
franklin
lake
nj
usa
analys
use
flowjo
softwar
tree
star
inc
ashland
usa
mice
subcutan
infect
dorsal
flank
ml
pb
contain
zikv
plaqueform
unit
assess
inhibitori
effect
viremia
ribavirin
mg
administ
intraperiton
consecut
day
postinfect
measur
viremia
rtpcr
perform
follow
total
rna
isol
amount
blood
serum
use
quickgen
rna
tissu
kit
sii
kurabo
osaka
japan
purifi
rna
subject
rtpcr
use
superscript
iii
onestep
rtpcr
system
platinum
taq
thermo
fisher
scientif
use
zikv
primer
zikv
envqpf
zikv
envqpr
tabl
fay
et
al
amplif
condit
follow
c
min
revers
transcript
c
min
denatur
cycl
c
c
c
amplif
quantit
analysi
cdna
gener
equival
amount
total
rna
blood
serum
use
verso
cdna
kit
realtim
rtpcr
perform
use
zikv
primer
zikv
envqpf
zikv
envqpr
tabl
primer
zikv
purchas
fasmac
sequenc
primer
list
tabl
analys
surviv
rate
ribavirin
mg
mg
intraperiton
administ
daili
start
day
infect
brain
sampl
homogen
complet
mem
homogen
clarifi
centrifug
titrat
perform
plaqu
assay
use
supernat
tissu
homogen
viral
titer
adjust
sampl
volum
tissu
weight
calcul
titer
pfug
use
unpair
student
ttest
logrank
test
evalu
statist
signific
differ
gener
ribavirin
prescrib
combin
type
ifn
patient
hcv
examin
whether
combin
ribavirin
ifnb
inhibit
zikv
replic
viral
suppress
assay
vero
cell
perform
rtpcr
assay
reveal
mgml
ribavirin
togeth
uml
ifnb
could
inhibit
viral
replic
complet
fig
next
assess
antivir
effect
reagent
zikv
replic
treatment
mgml
ribavirin
could
inhibit
zikv
replic
complet
significantli
treatment
mgml
ribavirin
could
inhibit
replic
almost
complet
fig
hand
treatment
uml
ifnb
could
almost
complet
suppress
viral
replic
fig
furthermor
low
amount
ribavirin
mgml
ifnb
uml
slightli
suppress
viral
replic
synergist
effect
observ
fig
sinc
vero
cell
defect
product
type
ifn
examin
antivir
effect
ribavirin
cell
line
normal
produc
type
ifn
infect
zikv
cell
human
neuroblastoma
cell
line
cell
aed
albopictu
cell
line
treat
cell
ribavirin
although
mgml
ribavirin
partial
suppress
viral
replic
vero
cell
could
strongli
inhibit
replic
cell
fig
moreov
treatment
cell
mgml
ribavirin
significantli
inhibit
zikv
replic
fig
result
suggest
ribavirin
effici
allevi
zikv
replic
immun
suffici
human
cell
mosquito
cell
zikv
infect
human
neural
progenitor
cell
caus
increas
activ
follow
cell
death
tang
et
al
henc
test
whether
ribavirin
would
inhibit
zikvinduc
apoptosi
cell
death
first
infect
vero
cell
zikv
presenc
variou
concentr
ribavirin
perform
plaqu
form
assay
ribavirin
inhibit
plaqu
format
partial
concentr
mgml
mgml
almost
complet
mgml
fig
b
similarli
uml
ifnb
partial
uml
ifnb
complet
suppress
plaqu
format
fig
result
suggest
ribavirin
ifnb
effect
prevent
zikvinduc
cell
death
vitro
confoc
microscop
analysi
reveal
uninfect
vero
cell
attach
surfac
cultur
dish
zikvinfect
vero
cell
detach
dish
absenc
ribavirin
fig
howev
ribavirin
allow
zikvinfect
vero
cell
attach
dish
concentr
mgml
presenc
mgml
ribavirin
addit
quantifi
apoptot
dead
cell
flow
cytometri
use
fluoresc
conjug
annexin
v
aminereact
fluoresc
dye
zombi
red
shown
fig
annexin
v
apoptot
cell
zombi
red
dead
cell
could
detect
uninfect
vero
cell
respect
hand
proport
dead
cell
zikvinfect
vero
cell
increas
consist
microscop
observ
ratio
dead
cell
began
reduc
concentr
mgml
mgml
ribavirin
though
proport
apoptot
cell
slightli
increas
ratio
apoptot
dead
cell
presenc
mgml
ribavirin
almost
compar
uninfect
cell
cytotox
observ
even
presenc
mgml
ribavirin
taken
togeth
result
suggest
ribavirin
prevent
zikvinduc
apoptosi
cell
death
without
cytotox
ganciclovir
potent
inhibitor
herp
famili
virus
includ
cytomegaloviru
crumpack
mechan
ganciclovir
interrupt
replic
viru
select
potent
inhibit
viral
dna
polymeras
matthew
boehm
report
plaqu
reduct
assay
fig
ganciclovir
effect
zikvinduc
apoptosi
cell
death
a
vero
cell
infect
zikv
moi
moi
h
adsorpt
methylcellulos
contain
ganciclovir
layer
cell
cell
incub
day
fix
formalin
stain
methylen
blue
photo
ganciclovir
inhibit
plaqu
format
concentr
mm
effect
tanaka
et
al
expect
ganciclovir
could
inhibit
plaqu
format
zikv
fig
b
moreov
inhibitori
effect
plaqu
format
observ
even
high
concentr
ganciclovir
mgml
fig
data
suggest
dna
polymeras
inhibitor
effect
zikv
final
investig
whether
ribavirin
control
zikv
replic
vivo
wildtyp
mice
resist
zikv
infect
wherea
mice
highli
suscept
infect
consist
previou
report
viremia
detect
wildtyp
mice
data
shown
function
signal
transduc
pathway
attempt
establish
zikvinfect
mous
model
use
mice
acut
weight
loss
observ
zikvinfect
mice
day
post
infect
die
day
post
infect
lose
origin
bodi
weight
fig
moreov
viral
infect
result
signific
hypothermia
day
post
infect
fig
two
day
prior
lethal
outcom
mice
display
abnorm
behavior
atax
gait
shiver
moreov
analys
viremia
rtpcr
assay
fig
intens
viremia
began
observ
day
post
infect
howev
interestingli
start
decreas
day
post
infect
subsequ
mice
die
day
post
infect
also
quantifi
viremia
realtim
rtpcr
assay
reveal
level
viremia
day
post
infect
thousand
time
greater
day
post
infect
fig
suggest
rapid
robust
viru
replic
mice
result
indic
mice
use
mous
model
lethal
infect
zikv
attempt
prevent
zikv
viremia
mice
treat
ribavirin
administr
mg
ribavirin
intraperiton
zikvinfect
mice
consecut
day
infect
although
ribavirin
treatment
suppress
viremia
day
infect
rtpcr
band
observ
day
discontinu
ribavirin
administr
day
post
infect
fig
ribavirin
treatment
significantli
suppress
level
viremia
day
post
infect
compar
untreat
mice
less
onetenth
onethousandth
respect
howev
level
viremia
compar
two
group
day
post
infect
fig
hand
ribavirin
treatment
fail
suppress
viral
load
brain
day
data
shown
day
post
infect
fig
moreov
daili
administr
mg
ribavirin
intraperiton
zikvinfect
mice
significantli
prolong
surviv
time
fig
consist
fig
intens
viremia
day
post
infect
inhibit
ribavirin
low
level
viremia
sustain
death
mice
fig
previou
report
administr
approxim
mg
ribavirin
denvinfect
mice
zikvinfect
mice
fail
reduc
viremia
mice
schul
et
al
chang
et
al
juland
et
al
thu
evalu
effect
low
dose
ribavirin
mous
model
howev
mg
ribavirin
could
suppress
viremia
prolong
surviv
suppl
fig
data
indic
highdos
ribavirin
effici
abrog
zikv
viremia
earli
stage
infect
lead
prolong
surviv
mice
healthi
adult
sever
case
zikv
infect
uncommon
infect
asymptomat
duffi
et
al
petersen
et
al
slavov
et
al
howev
zikv
infect
pregnant
women
result
microcephali
development
disord
newborn
repres
major
public
health
problem
resolv
issu
rapid
develop
drug
use
prevent
zika
fever
necessari
take
sever
year
develop
new
drug
test
wide
use
antivir
drug
examin
efficaci
zikv
hcv
zikv
belong
famili
flavivirida
hypothes
ribavirin
drug
use
treat
hepat
c
would
exert
suppress
effect
zikv
although
report
ribavirin
inhibit
zikv
replic
vero
cell
juland
et
al
found
ribavirin
potent
inhibit
zikv
replic
vero
cell
also
human
neuroblastoma
cell
line
fig
addit
ifnb
also
inhibit
zikv
replic
vero
cell
though
combin
exert
synergist
effect
fig
sinc
zikaendem
area
develop
countri
ifnb
expens
clinic
applic
ifnb
difficult
area
studi
examin
efficaci
ribavirin
zikv
infect
afford
drug
ribavirin
whose
safeti
alreadi
demonstr
wide
use
therapeut
drug
hepat
c
ribavirin
inhibit
viral
rnadepend
rna
polymeras
bougi
bisaillon
maag
et
al
toltzi
et
al
mrna
cap
format
goswami
et
al
inde
ribavirin
could
inhibit
replic
denv
middl
east
respiratori
syndrom
mer
coronaviru
sever
acut
respiratori
syndrom
sar
coronaviru
falzarano
et
al
falzarano
et
al
rattanabure
et
al
koren
et
al
suggest
ribavirin
could
effect
rna
virus
thu
reason
predict
ribavirin
could
also
suppress
replic
zikv
singlestrand
positivesens
rna
viru
blood
concentr
ribavirin
reach
approxim
mgml
follow
intraven
inject
mg
ribavirin
human
koren
et
al
data
indic
mgml
ribavirin
could
almost
complet
inhibit
zikv
replic
human
cell
fig
suggest
possibl
applic
ribavirin
zika
fever
howev
use
shortterm
treatment
longterm
oral
administr
ribavirin
caus
hemolyt
anemia
frequent
side
effect
bausch
et
al
brochot
et
al
koren
et
al
poynard
et
al
russmann
et
al
major
side
effect
report
shortterm
treatment
acut
lassa
fever
sever
intraven
shot
mg
ribavirin
bausch
et
al
mccormick
et
al
argu
ribavirin
contraind
pregnant
patient
teratogen
activ
hamster
rat
embryo
ferm
et
al
recent
new
drug
ledipasvir
sofosbuvir
adopt
therapeut
drug
hepat
c
although
adequ
data
regard
risk
human
pregnanc
advers
development
outcom
drug
observ
anim
studi
highlight
prescrib
inform
sovaldi
highlight
prescrib
inform
harvoni
recent
studi
report
sofosbuvir
inhibit
zika
viru
infect
bullardfeibelman
et
al
though
would
difficult
use
drug
develop
countri
expens
gener
zikv
infect
mainli
primat
wildtyp
mice
mous
model
report
far
exampl
mice
lack
type
ifn
receptor
highli
suscept
zikv
infect
furthermor
sjl
mice
defect
type
ifn
signal
infect
zikv
report
vertic
infect
could
occur
transplacent
transmiss
zikvinfect
pregnant
sjl
mice
cugola
et
al
howev
fail
confirm
zikv
infect
sjl
mice
viremia
lethal
outcom
observ
data
shown
studi
found
mice
lack
type
ifn
signal
highli
sensit
zikv
infect
exhibit
lethal
outcom
viremia
observ
day
infect
howev
level
viremia
decreas
day
infect
without
treatment
unknown
reason
use
mous
model
demonstr
ribavirin
could
success
control
zikv
viremia
prolong
surviv
time
significantli
fig
e
howev
zikv
load
brain
compar
ribavirintr
untreat
group
day
post
infect
fig
low
level
viremia
observ
death
mice
treat
ribavirin
fig
suggest
ribavirin
could
complet
elimin
zikv
result
account
lethal
outcom
zikvinfect
mice
howev
mechan
underli
prolong
mous
surviv
still
uncertain
shown
administr
ribavirin
first
three
day
infect
fail
prolong
surviv
infect
mice
even
though
treat
mg
ribavirin
fig
schul
et
al
treat
denvinfect
mice
mgkg
ribavirin
dayconsecut
administr
contrari
continu
administr
mg
ribavirin
throughout
cours
infect
could
success
prolong
surviv
fig
thu
treatment
regimen
critic
control
zikv
hand
daili
administr
mg
lower
dose
ribavirin
resembl
dose
use
group
schul
et
al
chang
et
al
juland
et
al
could
prolong
surviv
zikvinfect
mice
supplementari
fig
data
suggest
daili
administr
high
concentr
ribavirin
requir
prolong
surviv
time
zikvinfect
mice
although
low
dose
ribavirin
could
inhibit
viral
replic
judg
rtpcr
assay
fig
high
dose
ribavirin
requir
suppress
apoptosi
infect
cell
judg
plaqu
assay
fig
thu
even
viremia
judg
rtpcr
assay
appear
suppress
apoptosi
cerebr
nerv
cell
might
induc
mechan
underli
lethal
outcom
zikvinfect
mice
remain
solv
